ロード中...
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Type 2 diabetes mellitus is a chronic metabolic disease associated with high cardiovascular (CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of antidiabetic medication that inhibit the absorption of glucose from the proximal tubule of the kidney and hence cause gly...
保存先:
| 出版年: | Int J Environ Res Public Health |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6720282/ https://ncbi.nlm.nih.gov/pubmed/31426529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph16162965 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|